Clinical Trial Update: Open-Label, Randomised, Multi-Drug, Biomarker-Directed, Phase 1b Study in Pts w/ Muscle Invasive Bladder Cancer [Phase 1]

View source ↗

Summary

An open-label, randomized Phase 1b study evaluating a multi-drug, biomarker-directed approach in patients with muscle-invasive bladder cancer; current status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle-invasive Bladder Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Muscle Invasive Bladder Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING